Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cannabis and Cannabinoid Research is Scopus-indexed (Q1, CiteScore 7.6), WoS SCIE. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 2378-8763Verify ISSN ↗2578-5125Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Complementary and Alternative Medicine | 12 / 115 | 90th | Q1 |
| Pharmacology (medical) | 47 / 278 | 83rd | Q1 |
| Pharmacology | 71 / 328 | 78th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2016–present, best quartile Q1, CiteScore 7.6.
Cannabis and Cannabinoid Research is Q1 in Complementary and Alternative Medicine (rank 12 of 115), Q1 in Pharmacology (medical) (rank 47 of 278) and Q1 in Pharmacology (rank 71 of 328), by CiteScore 2025.
Cannabis and Cannabinoid Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.6, which places it in quartile Q1 at the 90th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.027, quartile Q1, with an H-index of 52.
Cannabis and Cannabinoid Research is published by SAGE Publications Ltd. Its print ISSN is 2378-8763 and its online ISSN is 2578-5125.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Cannabis and Cannabinoid Research has an h-index of 61 and a 2-year mean of 2.96 citations per paper (OpenAlex). Its Scopus CiteScore is 7.6, quartile Q1. On 2-year citations it ranks #23 of 109 Scopus journals in Complementary and Alternative Medicine.
Cannabis and Cannabinoid Research published 57 papers in 2025; its busiest recent year was 2022 with 142. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2024–2026), authors are most often from United States (61.2%), Australia (7.7%) and Brazil (7.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.